September 22, 2015 / 3:36 PM / in 2 years

BUZZ-Biotech stocks: Falls on Hillary Clinton's monthly cap proposal

** Nasdaq Biotechnology Index down about 3 pct; S&P health care down 1.35 pct

** Democratic presidential candidate Hillary Clinton will propose on Tuesday a $250 monthly cap on prescription drugs to stop what she calls “excessive profiteering” by pharmaceutical companies

** Valeant Pharmaceuticals International Inc down about 5 pct, Gilead Sciences Inc down 2 pct, AbbVie Inc down 3 pct

** Biogen Inc down 1.5 pct; Johnson and Johnson down 1 pct; Celgene Corp down 3 pct

** Retrophin Inc down 10 pct; among the top percentage losers on the Biotech index

** Biotech stocks slumped on Monday after Clinton tweeted her intent to tackle unnecessarily high prices in some drug markets

** Up to Monday’s close, the Nasdaq biotechnology index had risen 12 pct

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below